Aptevo Therapeutics Inc. (APVO)

NasdaqCM • Currently up 0.01 (+0.62%) in today's trading session

1 member of Congress has disclosed 2 trades in Aptevo Therapeutics Inc. (APVO) via STOCK Act filings. The most recent disclosure was a sale by Steve Cohen on 24 June 2019.

Aptevo Therapeutics Inc. is currently trading at $1.61, positioned at 1% of its 52-week range ($1.37 – $28.44).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$1.61
24h Change
+0.01 (+0.62%)
52 Week Range
$1.37–$28.44
View on NASDAQ

Aptevo Therapeutics Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for APVO

Select to highlight on chart
2 transactions
Compliance: 50%
Steve Cohen24 Jun 20193 Jul 2019SaleStock$470.99N/A
Steve Cohen24 Jun 201913 Aug 2020SaleStock$470.99N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.52M

Volume

5.28K

Beta

1.68

P/E Ratio

-

Fundamentals

EPS

$1486.87

Div. Yield

-

Open

$1.60

Day Range

$1.60 – $1.64

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Jeffrey G. Lamothe
IPO Date
2016-07-20
Website
www.aptevotherapeutics.com

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antib...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$-3.72

Rev. Est.

-

Days Until

13

Recent Quarters

Q2 202614 Aug
EPS$-5.31
Beat 11.7%
Q1 202613 May
EPS$-6.41
Miss 14.5%
Q4 202520 Mar
EPS$1684.47
Beat 20921.6%
Q3 20256 Nov
EPS$-40.11
Miss 6.7%
Q2 202511 Aug
EPS$-151.20
Miss 81.7%
Q1 202515 May
EPS$-1579.14
Miss 37409.3%
Q4 20244 Mar
EPS$-3218.40
Miss 41427.7%
Q3 20247 Nov
EPS$-6255.86
Beat 15.8%
Q2 20248 Aug
EPS$-21765.20
Beat 13.5%
Q1 20248 May
EPS$-129678.87
Beat 29.4%
Q4 20236 Mar
EPS$-6.16
Beat 65.8%
Q3 202314 Nov
EPS$-287071.63
Q2 202310 Aug
EPS$-706196.19
Q1 202311 May
EPS$149277.23
Q4 202230 Mar
EPS$-0.95
Beat 37.9%
Q3 202210 Nov
EPS$-67.43
Miss 4011.3%
Q2 202211 Aug
EPS$-1067906.38
Miss 39.9%
Q1 202212 May
EPS$-9128.88
Miss 38.3%
Q4 202124 Mar
EPS$-1.27
Beat 1.6%
Q3 202112 Nov
EPS$-8325.08
Beat 2.0%
Q2 202112 Aug
EPS$-10219.75
Beat 8.7%
Q1 202111 May
EPS$-9990.09
Miss 7.4%
Q4 202031 Mar
EPS$-1.92
Miss 57.4%
Q3 202010 Nov
EPS$-12344.08
Miss 4.9%
Q2 202014 Aug
EPS$-12057.01
Beat 7.5%
Q1 202013 May
EPS$-1389426.63
Beat 5.1%
Q4 201925 Mar
EPS$-2.38
Beat 33.7%
Q3 20197 Nov
EPS$-18494.81
Beat 4.2%
Q2 20199 Aug
EPS$-24123.67
Beat 21.1%
Q1 20199 May
EPS$-35381.38
Beat 8.3%
Q4 201818 Mar
EPS$-8.68
Miss 16.2%
Q3 201814 Nov
EPS$-45030.84
Beat 5.1%
Q2 20189 Aug
EPS$-46639.08
Beat 10.8%
Q1 201810 May
EPS$-50659.69
Miss 12.5%
Q4 201713 Mar
EPS$-6.44
Miss 43.8%
Q3 20179 Nov
EPS$11257.71
Miss 93.8%
Q2 201710 Aug
EPS$-42618.47
Q1 201712 May
EPS$-38597.86
Beat 32.4%
Q4 201631 Mar
EPS$804.12
Q3 201614 Nov
EPS$-64329.77
Miss 25.0%
Q2 201626 Aug
EPS$-28941.40
Q4 201531 Mar
EPS$-266540.87
Q3 201531 Dec
EPS$-403292.63
Q2 201530 Sept
EPS$-285716.31
Q1 201530 Jun
EPS$-399191.65
Q4 201431 Mar
EPS$-248356.88

No dividend data available for this stock.

Stock Splits

Split History

30 Dec 2025Reverse Split
Ratio1:18
27 May 2025Reverse Split
Ratio1:20
4 Dec 2024Reverse Split
Ratio1:37
6 Mar 2024Reverse Split
Ratio1:44
27 Mar 2020Reverse Split
Ratio1:14

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about APVO

Which members of Congress have traded APVO?
1 member of Congress has disclosed 2 trade in Aptevo Therapeutics Inc. (APVO) under the STOCK Act: Steve Cohen.
When was APVO most recently disclosed by Congress?
The most recent APVO disclosure was a sale by Steve Cohen on 24 June 2019.
How can I track new congressional trades in APVO?
This APVO page updates as soon as new STOCK Act disclosures are filed for Aptevo Therapeutics Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.